SCHEMBL9316406

SCHEMBL9316406

CCCC[C@@](N)(C(=O)O)C(O)c1cc(O)ccc1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.38
ESR2 Q92731 3/20 0.38
KDM4E B2RXH2 2/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 2/20 0.37
CYP3A4 P08684 2/20 0.37
MAPT P10636 2/20 0.37
ALOX15 P16050 2/20 0.37
BLM P54132 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
GAA P10253 2/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
EGFR P00533 1/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716367 0.87 ESR1 (0.38) ESR1ESR2KDM4EHTTMEN1
SCHEMBL6717504 0.78 HSD17B10 (0.38) ESR1ESR2KDM4EHTTMEN1
SCHEMBL9317724 0.76 HSD17B10 (0.43) KDM4EHTTMEN1CYP3A4MAPT
SCHEMBL6724468 0.75 HSD17B10 (0.37) ESR1ESR2KDM4EHTTMEN1
SCHEMBL6811148 0.70 ESR1 (0.46) ESR1ESR2KDM4EHTTMEN1
SCHEMBL6716430 0.70 KYNU (0.40) KDM4EHTTMEN1KMT2ATDP1
SCHEMBL27665577 0.70 HSD17B10 (0.47) KDM4EHTTMEN1CYP3A4MAPT
SCHEMBL9316845 0.69 ADRB2 (0.35) KDM4EMEN1CYP3A4MAPTALOX15
SCHEMBL4148827 0.69 HTT (0.42) KDM4EHTTMEN1CYP3A4MAPT
SCHEMBL27665666 0.68 HSD17B10 (0.44) ESR1ESR2KDM4EHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0484437-A4 RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION SEARLE & CO (US) 1994-06-01 EP claimed
EP-0484437-A1 RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION G.D. Searle & Co. (US) 1992-05-13 EP claimed